HUP0104611A2 - Thiourea inhibitors of herpes viruses and medicaments containing them - Google Patents
Thiourea inhibitors of herpes viruses and medicaments containing themInfo
- Publication number
- HUP0104611A2 HUP0104611A2 HU0104611A HUP0104611A HUP0104611A2 HU P0104611 A2 HUP0104611 A2 HU P0104611A2 HU 0104611 A HU0104611 A HU 0104611A HU P0104611 A HUP0104611 A HU P0104611A HU P0104611 A2 HUP0104611 A2 HU P0104611A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- alkyl
- compounds
- virus
- alkoxy
- Prior art date
Links
- 241001529453 unidentified herpesvirus Species 0.000 title abstract 3
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 title 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 abstract 1
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 abstract 1
- 241000701085 Human alphaherpesvirus 3 Species 0.000 abstract 1
- 241000701024 Human betaherpesvirus 5 Species 0.000 abstract 1
- 241000701041 Human betaherpesvirus 7 Species 0.000 abstract 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 abstract 1
- 241000701027 Human herpesvirus 6 Species 0.000 abstract 1
- 241000700584 Simplexvirus Species 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
A tal lm ny (I) ltal nos képletű vegyületekre és gyógy szatilagelfogadható sóikra vonatkozik, ahol A jelentése heteroarilcsoport; R9-R12 jelentése egym stól függetlenül hidrogénatom, 1-4 szénatomosalkil-, 1-4 szénatomos perhalogénalkil-, halogénatom, 1-4 szénatomosalkoxi-, cianocsoport vagy R9 és R10 vagy R11 és R12 5-7 szénatomottartalmazó arilcsoportot alkothat; G jelentése aril- vagyheteroarilcsoport; X jelentése vegyértékk"tés, -NH-, 1-6 szénatomosalkil-, 1-6 szénatomos alkenil-, 1-6 szénatomos alkoxi-, 1-6szénatomos alkil- tio-, 1-6 szénatomos alkil-aminocsoport vagy (CH)Jltal nos képletű csoport; J jelentése 1-6 szénatomos alkil-, 3-7szénatomos cikloalkil-, fenil- vagy benzilcsoport. A vegyület aherpeszvírusok, péld ul a hum n citomegalavírusok, herpesz szimplexvírusok, Epstein-Barr vírus, varicella-zoster vírus, hum nherpeszvírus-6 és -7 és a Kaposi-herpeszvírus ltal okozott betegségekkezelésére haszn lhatók. A tal lm ny a vegyületeket tartalmazógyógyszerkészítményekre és a vegyületek alkalmaz s ra is vonatkozik. ÓThe invention relates to compounds of formula (I) and their pharmaceutically acceptable salts, where A is a heteroaryl group; R9-R12 are independently a hydrogen atom, a C1-4 alkyl, a C1-4 perhaloalkyl, a halogen atom, a C1-4 alkoxy, a cyano group, or R9 and R10 or R11 and R12 can form an aryl group containing 5-7 carbon atoms; G is aryl or heteroaryl; X is valence, -NH-, C1-6 alkyl-, C1-6 alkenyl-, C1-6 alkoxy-, C1-6 alkylthio-, C1-6 alkylamino group or (CH) a group of the formula nos; J is a C1-C6 alkyl, C3-C7 cycloalkyl, phenyl or benzyl group. The compound is a herpesvirus, e.g. human cytomegalovirus, herpes simplex virus, Epstein-Barr virus, varicella-zoster virus, human herpesvirus -6 and -7 and can be used for the treatment of diseases caused by the Kaposi's herpes virus. The information also applies to pharmaceutical preparations containing the compounds and the application of the compounds.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20796198A | 1998-12-09 | 1998-12-09 | |
PCT/US1999/028838 WO2000034268A1 (en) | 1998-12-09 | 1999-12-06 | Thiourea inhibitors of herpes viruses |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0104611A2 true HUP0104611A2 (en) | 2002-04-29 |
HUP0104611A3 HUP0104611A3 (en) | 2002-10-28 |
Family
ID=22772683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0104611A HUP0104611A3 (en) | 1998-12-09 | 1999-12-06 | Thiourea inhibitors of herpes viruses and medicaments containing them |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1137647A1 (en) |
JP (1) | JP2002531557A (en) |
KR (1) | KR20010086090A (en) |
CN (1) | CN1333769A (en) |
AU (1) | AU3111100A (en) |
BR (1) | BR9915993A (en) |
CA (1) | CA2350996A1 (en) |
CZ (1) | CZ20012057A3 (en) |
EA (1) | EA200100635A1 (en) |
HU (1) | HUP0104611A3 (en) |
IL (1) | IL143261A0 (en) |
NO (1) | NO20012837L (en) |
PL (1) | PL349043A1 (en) |
WO (1) | WO2000034268A1 (en) |
ZA (1) | ZA200104318B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6844367B1 (en) | 1999-09-17 | 2005-01-18 | Millennium Pharmaceuticals, Inc. | Benzamides and related inhibitors of factor Xa |
WO2001064642A2 (en) | 2000-02-29 | 2001-09-07 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
NZ544674A (en) * | 2003-07-10 | 2009-03-31 | Achillion Pharmaceuticals Inc | Substituted arylthiourea derivatives useful as inhibitors of viral replication |
WO2006019955A2 (en) * | 2004-07-14 | 2006-02-23 | President And Fellows Of Harvard College | Antiviral methods and compositions |
KR101013183B1 (en) * | 2006-04-14 | 2011-02-10 | 남명숙 | Plate for observing moon |
ES2382055T3 (en) | 2006-11-02 | 2012-06-04 | Millennium Pharmaceuticals, Inc. | Methods for synthesizing pharmaceutical salts of a factor Xa inhibitor |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69830751T2 (en) * | 1997-04-10 | 2006-05-18 | Pharmacia & Upjohn Co. Llc, Kalamazoo | Polyaromatic compounds for the treatment of herpes infections |
-
1999
- 1999-12-06 EP EP99965131A patent/EP1137647A1/en not_active Withdrawn
- 1999-12-06 CA CA002350996A patent/CA2350996A1/en not_active Abandoned
- 1999-12-06 IL IL14326199A patent/IL143261A0/en unknown
- 1999-12-06 CZ CZ20012057A patent/CZ20012057A3/en unknown
- 1999-12-06 EA EA200100635A patent/EA200100635A1/en unknown
- 1999-12-06 BR BR9915993-7A patent/BR9915993A/en not_active Application Discontinuation
- 1999-12-06 KR KR1020017007115A patent/KR20010086090A/en not_active Application Discontinuation
- 1999-12-06 PL PL99349043A patent/PL349043A1/en not_active Application Discontinuation
- 1999-12-06 HU HU0104611A patent/HUP0104611A3/en unknown
- 1999-12-06 JP JP2000586715A patent/JP2002531557A/en active Pending
- 1999-12-06 WO PCT/US1999/028838 patent/WO2000034268A1/en not_active Application Discontinuation
- 1999-12-06 CN CN99815821A patent/CN1333769A/en active Pending
- 1999-12-06 AU AU31111/00A patent/AU3111100A/en not_active Abandoned
-
2001
- 2001-05-25 ZA ZA200104318A patent/ZA200104318B/en unknown
- 2001-06-08 NO NO20012837A patent/NO20012837L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000034268A1 (en) | 2000-06-15 |
HUP0104611A3 (en) | 2002-10-28 |
ZA200104318B (en) | 2002-08-26 |
CZ20012057A3 (en) | 2001-11-14 |
BR9915993A (en) | 2001-09-04 |
AU3111100A (en) | 2000-06-26 |
JP2002531557A (en) | 2002-09-24 |
EP1137647A1 (en) | 2001-10-04 |
CA2350996A1 (en) | 2000-06-15 |
IL143261A0 (en) | 2002-04-21 |
NO20012837L (en) | 2001-07-19 |
CN1333769A (en) | 2002-01-30 |
KR20010086090A (en) | 2001-09-07 |
EA200100635A1 (en) | 2001-12-24 |
PL349043A1 (en) | 2002-07-01 |
NO20012837D0 (en) | 2001-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0368640A3 (en) | Heterocyclic compounds | |
AU2866297A (en) | Neuraminic acid derivatives, their preparation and their medical use | |
AU2736088A (en) | Pharmaceutical compositions comprising benzylidene- and cinnamylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells, certain such novel compounds and their preparation | |
GB9211172D0 (en) | Compounds | |
AU1400801A (en) | Aralkyl-1,2-diamines having calcimimetic activity and preparation mode | |
HUP0104611A2 (en) | Thiourea inhibitors of herpes viruses and medicaments containing them | |
AU2868689A (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
HUP0200232A2 (en) | Phenylenediamine group and heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses their use and pharmaceutical compositions containing them | |
WO2000034237A3 (en) | Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses | |
HUP0104763A2 (en) | Thiourea inhibitors of herpes viruses | |
HUP0203405A2 (en) | A substituted phenylenediamine group and heterocyclic carboxamide group containing thiourea derivatives inhibitors of herpes viruses, pharmaceutical compositions containing them and their use | |
HUP9902992A3 (en) | Alpha-amino acid amides, preparation thereof and pharmaceutical compositions containing them | |
HUP0104492A2 (en) | Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group | |
DK149058C (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF 4- (4,4- (DIPHENYL) BUTYL) -1-ACYL PIPERAZINES OR ACID ADDITION SALTS. | |
DK0640612T3 (en) | New derivatives of 2- (1H) -quinolinone, process for their preparation and pharmaceutical compositions containing | |
BR9916042A (en) | Compound, pharmaceutical composition, and processes to inhibit the replication of a herpes virus, and treatment of a patient suffering from a herpes virus infection | |
ES8600224A1 (en) | Carbamyloxybenzhydrole derivatives, process for their preparation and pharmaceutical compositions containing them. | |
ES8201979A1 (en) | Biphenylyl-imidazolylethane derivatives, process for their preparation and medicaments containing them. | |
DK301386A (en) | HYDROXYALCOXY-4-PHENYLPROPYLIN DERIVATIVE DERIVATIVES AND SALTS THEREOF, THEIR PREPARATION AND INTERMEDIATES THEREOF AND MEDICINAL PRODUCTS CONTAINING THEREOF | |
DK96086D0 (en) | 8-THIOTETRAHYDROQUINOLINE DERIVATIVES, THEIR PREPARATION AND USE OF MEDICINAL PRODUCTS | |
BG106613A (en) | Phenyl-and pyridyl-tetrahydro-pyridines having tnf inhibiting activity | |
SE8503054D0 (en) | CATECHOLCARBOXAMIDES | |
DK0379414T3 (en) | Derivatives of 1,8-benzonaphthyridine and their preparation | |
ES2021940A6 (en) | Pyrimidine derivatives, 2-[4-(alpha-heteroaryl-alpha-aryl-(alpha-alkyl)-methoxy)-butyl)-1-piperazinyl], with a serotoninergical activity. | |
ATE151987T1 (en) | USE OF 3-PYRIDAZINONE TO REDUCE PLATELE COUNTS |